Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Bone Marrow Transplantation|September 29, 2023
T-cell depleted allogeneic hematopoietic stem cell transplant for the treatment of Fanconi anemia and MDS/AMLAlexandra M Satty, Elizabeth Klein, Audrey Mauguen, et al.
Blood|November 5, 2020
CD4+ T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: a dual-center validationCoco de Koning, Susan Prockop, Ichelle van Roessel, et al.
Pediatric Blood & Cancer|September 1, 2024
Craniospinal irradiation and/or intraventricular radioimmunotherapy after high-dose chemotherapy and autologous stem cell rescue in patients with CNS retinoblastoma-Safety and outcomesSameer Farouk Sait, Nancy A Kernan, Elizabeth Klein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2021
Therapeutic Efficacy of Combined JAK1/2, Pan-PIM, and CDK4/6 Inhibition in Myeloproliferative NeoplasmsRaajit K Rampal, Maria Pinzon-Ortiz, Amritha Varshini Hanasoge Somasundara, et al.
Blood Advances|December 26, 2023
High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancerAaron J Stonestrom, Kamal N Menghrajani, Sean M Devlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 17, 2017
A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid MalignanciesBarbara Spitzer, Ann A Jakubowski, Esperanza B Papadopoulos, et al.
The Journal of Clinical Investigation|January 23, 2018
JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibitionAnna Sophia McKenney, Allison N Lau, Amritha Varshini Hanasoge Somasundara, et al.
Oncotarget|November 9, 2016
Acid ceramidase is upregulated in AML and represents a novel therapeutic targetSu-Fern Tan, Xin Liu, Todd E Fox, et al.
Blood Advances|June 28, 2023
Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantationRoni Tamari, Michael Scordo, Binni M Kunvarjee, et al.
Blood|October 26, 2019
Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALLKevin J Curran, Steven P Margossian, Nancy A Kernan, et al.
Pageof 5